Cancer immunotherapy with PI3K and PD-1 dual-blockade via optimal modulation of T cell activation signal
========================================================================================================

* Sho Isoyama
* Shigeyuki Mori
* Daisuke Sugiyama
* Yasuhiro Kojima
* Yasuko Tada
* Kohei Shitara
* Kunihiko Hinohara
* Shingo Dan
* Hiroyoshi Nishikawa